Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Property, Plant & Equipment (Net) (2011 - 2025)

Analysis

Verastem (VSTM) Property, Plant & Equipment (Net) (2011 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 20,000.00
Jun 30, 2025 21,000.00
Mar 31, 2025 22,000.00
Dec 31, 2024 32,000.00
Sep 30, 2024 39,000.00
Jun 30, 2024 46,000.00
Mar 31, 2024 52,000.00
Dec 31, 2023 37,000.00
Sep 30, 2023 35,000.00
Jun 30, 2023 40,000.00
Mar 31, 2023 62,000.00
Dec 31, 2022 92,000.00
Sep 30, 2022 121,000.00
Jun 30, 2022 151,000.00
Mar 31, 2022 180,000.00
Dec 31, 2021 210,000.00
Sep 30, 2021 240,000.00
Jun 30, 2021 270,000.00
Mar 31, 2021 335,000.00
Dec 31, 2020 416,000.00